Tower Research Capital (TRC)’s NeueHealth NEUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-330
| Closed | -$2.2K | – | 5682 |
|
|
2025
Q3 | $2.2K | Buy |
+330
| New | +$2.22K | ﹤0.01% | 4669 |
|
|
2025
Q2 | – | Sell |
-66
| Closed | -$446 | – | 5619 |
|
|
2025
Q1 | $446 | Buy |
+66
| New | +$462 | ﹤0.01% | 4894 |
|
|
2024
Q3 | – | Sell |
-975
| Closed | -$5.3K | – | 6036 |
|
|
2024
Q2 | $5.3K | Sell |
975
-895
| -48% | -$5.32K | ﹤0.01% | 4696 |
|
|
2024
Q1 | $12.2K | Buy |
+1,870
| New | +$16.7K | ﹤0.01% | 3507 |
|
|
2023
Q4 | – | Sell |
-1,329
| Closed | -$7.93K | – | 6207 |
|
|
2023
Q3 | $7.93K | Buy |
+1,329
| New | +$13.7K | ﹤0.01% | 4420 |
|
|
2023
Q2 | – | Sell |
-660
| Closed | -$12K | – | 6404 |
|
|
2023
Q1 | $12K | Buy |
660
+131
| +25% | +$6.75K | ﹤0.01% | 4135 |
|
|
2022
Q4 | $27K | Buy |
529
+450
| +570% | +$32.7K | ﹤0.01% | 2853 |
|
|
2022
Q3 | $7K | Sell |
79
-12
| -13% | -$1.59K | ﹤0.01% | 4941 |
|
|
2022
Q2 | $13K | Buy |
91
+40
| +78% | +$5.82K | ﹤0.01% | 4234 |
|
|
2022
Q1 | $8K | Sell |
51
-4
| -7% | -$888 | ﹤0.01% | 4626 |
|
|
2021
Q4 | $15K | Buy |
55
+39
| +244% | +$18K | ﹤0.01% | 4017 |
|
|
2021
Q3 | $11K | Sell |
16
-186
| -92% | -$164K | ﹤0.01% | 4268 |
|
|
2021
Q2 | $277K | Buy |
+202
| New | +$277K | 0.01% | 1674 |
|
Tower Research Capital (TRC)'s NEUE Position: Q4 2025 in Review
Tower Research Capital (TRC) sold out of NeueHealth (NEUE) in Q4 2025, closing a stake of 330 shares — an estimated $2.2K sold.
Tower Research Capital (TRC) first reported a position in NEUE in Q2 2021 and held it in 13 quarters. The position peaked at $277K in Q2 2021. 0 funds tracked by Wall St. Rank hold NEUE as of Q4 2025.
- Tower Research Capital (TRC) reported no remaining NeueHealth position as of Q4 2025 after selling out during the quarter.
- Tower Research Capital (TRC) sold 330 NeueHealth shares in Q4 2025, an estimated $2.2K.
- Tower Research Capital (TRC) first reported a position in NeueHealth in Q2 2021 and held it in 13 quarters.
- Tower Research Capital (TRC)'s NeueHealth position peaked at $277K in Q2 2021.
- 0 funds tracked by Wall St. Rank held NeueHealth as of Q4 2025.
Based on Tower Research Capital (TRC)'s 13F filing for Q4 2025, filed 17 Feb 2026.